Showing results (581-590 of 991) with videos related to
Sort By:
Pageof 100
Therapeutic Advances in Respiratory Disease|October 18, 2025
What is the Asthma Impairment and Risk Questionnaire and how can it help patients with asthma? A plain language summary of publicationsMaureen George, Bradley E Chipps, David A Beuther, et al.Therapeutic Advances in Respiratory Disease|July 19, 2014
The safety of asthma medications during pregnancy: an update for cliniciansJennifer A Namazy, Michael SchatzTherapeutic Advances in Respiratory Disease|July 19, 2014
Current best practice in the management of pulmonary and systemic sarcoidosisEmily N Amin, Douglas R Closser, Elliott D CrouserTherapeutic Advances in Respiratory Disease|September 6, 2013
Ivacaftor treatment of cystic fibrosis patients with the G551D mutation: a review of the evidenceKavitha Kotha, John P ClancyTherapeutic Advances in Respiratory Disease|May 9, 2013
Costs of chronic obstructive pulmonary disease in relation to compliance with guidelines: a study in the primary care settingMarc Miravitlles, Antoni Sicras, Carles Crespo, et al.Therapeutic Advances in Respiratory Disease|March 30, 2013
Beta-blocker management of refractory hemoptysis in cystic fibrosis: a novel treatment approachJohn Moua, Eliezer Nussbaum, Eileen Liao, et al.Therapeutic Advances in Respiratory Disease|March 1, 2013
Inhaled corticosteroids and the increased risk of pneumoniaLucía Marzoratti, Hernán A Iannella, Grant W WatererTherapeutic Advances in Respiratory Disease|February 27, 2013
Early life influences on the development of chronic obstructive pulmonary diseaseJanet Stocks, Samatha SonnappaTherapeutic Advances in Respiratory Disease|December 22, 2012
Bronchoscopic staging of lung cancerWaël C Hanna, Kazuhiro YasufukuTherapeutic Advances in Respiratory Disease|January 9, 2013
Indacaterol 75 μg once daily for the treatment of patients with chronic obstructive pulmonary disease: a North American perspectiveEdward M Kerwin, James WilliamsPageof 100